Nine-year progression of untreated pulmonary Mycobacterium szulgai infection

South Med J. 2010 Aug;103(8):828-30. doi: 10.1097/SMJ.0b013e3181e6cc26.

Abstract

A 58-year-old man was seen with complaints of fevers, night sweats, weight loss, and multiple bilateral cavitary lung lesions. Mycobacterium szulgai with nearly identical antibiograms grew from separate sputum specimens 9 years apart. He was treated with a combination of clarithromycin and ethambutol with clinical, microbiologic, and radiographic resolution of disease. This is the longest untreated case of documented Mycobacterium szulgai infection reported, and offers a glimpse of its natural history when left untreated. Despite an infrequent isolation (<0.5% of cases), it is a pathogenic organism which warrants treatment.

Publication types

  • Case Reports

MeSH terms

  • Antitubercular Agents / administration & dosage
  • Antitubercular Agents / therapeutic use
  • Clarithromycin / administration & dosage
  • Clarithromycin / therapeutic use
  • Delayed Diagnosis
  • Disease Progression
  • Drug Therapy, Combination
  • Ethambutol / administration & dosage
  • Ethambutol / therapeutic use
  • Humans
  • Lung Diseases / diagnosis
  • Lung Diseases / drug therapy
  • Lung Diseases / microbiology*
  • Male
  • Middle Aged
  • Mycobacterium Infections, Nontuberculous / diagnosis
  • Mycobacterium Infections, Nontuberculous / drug therapy
  • Mycobacterium Infections, Nontuberculous / microbiology*
  • Nontuberculous Mycobacteria*

Substances

  • Antitubercular Agents
  • Ethambutol
  • Clarithromycin